The DOI matches its Crossref record; 288 of the 288 references it cites were found in a registry or an index.
Cancer and Bone*
Abstract
CANCER is associated with significant morbidity in the skeleton. This was evident as early as 1889 when Stephen Paget (1) observed that “in a cancer of the breast the bones suffer in a special way, which cannot be explained by any theory of embolism alone… the same thing is seen much more clearly in those cases of cancer of the thyroid body where secondary deposition occurs in the bones with astonishing frequency.” He also noted that “a general degradation of the bones sometimes occurs in carcinoma of the breast, yet without any distinct deposition of cancer in them.” These early observations were profound as it is now clear that cancer can involve bone through both metastatic and humoral mechanisms. Since the time of Paget, it has become clear that cancer affects bone in several ways: 1) indirectly through elaboration of factors that act systemically on target organs of bone and kidney to disrupt normal calcium homeostasis; 2) locally and directly via secondary spread of tumor to bone; and 3) via direct involvement by primary bone tumors. As primary bone tumors comprise a small minority of all tumors affecting bone, this review will focus on the aspects of cancer and bone related to the former only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–288 of 288
Bone and cancer: Pathophysiology and treatment of metastases
Kanis, J. А. (1995) · Bone · doi:10.1016/8756-3282(95)00194-i · Cited by 108
PTH secretion in vivo and in vitro. Regulation by calcium and other secretagogues.
Em, B. (1983) · PubMed · Cited by 107
Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus.
Daifotis, A. G., Weir, E. C., Dreyer, B. E., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35857-5 · Cited by 105
Characteristics of prostate-derived growth factors for cells of the osteoblast phenotype.
Koutsilieris, M., Rabbani, S. A., Bennett, H. P. J., & Goltzman, D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113186 · Cited by 105
Conover, C. A., Perry, J. E., & Tindall, D. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7533776 · Cited by 102
Pandian, M. R., MORGAN, C. H., Carlton, E. I., & Segre, G. V. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.2.282 · Cited by 101
Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells
Riet, I. V., Waele, M. D., Remels, L., et al. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08050.x · Cited by 100
Development of an in vivo model of human multiple myeloma bone disease
Alsina, M., Boyce, B. F., Devlin, R. D., Anderson, J. L., Craig, F. E., Mundy, G. R., & Roodman, G. D. (1996) · Blood · doi:10.1182/blood.v87.4.1495.bloodjournal8741495 · Cited by 97
Self-citationMetabolic Acidosis Suppresses 25-Hydroxyvitamin D3-1α-Hydroxylase in the Rat Kidney
Kawashima, H., Kraut, J. A., & Kurokawa, K. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110586 · Cited by 97
Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.
Monne, M. I., Croce, C. M., Yu, H., & Diamandis, E. P. (1994) · PubMed · Cited by 97
Iguchi, H., Tanaka, S., Ozawa, Y., Kashiwakuma, T., Kimura, T., Hiraga, T., Ozawa, H., & Kono, A. (1996) · PubMed · Cited by 97
Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Percival, R. C., Yates, A. J. P., Gray, R. E., Galloway, J., Rogers, K., Neal, F. E., & Kanis, J. A. (1985) · BMJ · doi:10.1136/bmj.291.6498.776 · Cited by 96
Zerwekh, J. E., & Breslau, N. A. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-192 · Cited by 95
Singer, F. R. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400030039007 · Cited by 93
Bouizar, Z., Spyratos, F., Deytieux, S., de Vernejoul, M. C., & Jullienne, A. (1993) · PubMed · Cited by 93
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia
Mundy, G. R., Rick, M. E., Turcotte, R., & Kowalski, M. A. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90847-1 · Cited by 92
Self-citationC8, a new member of the convertase family
Bruzzaniti, A., GOODGE, K. A., Jay, P., Taviaux, S. A., Lam, M. H. C., Berta, P., Martin, T. J., Moseley, J. M., & Gillespie, M. T. (1996) · Biochemical Journal · doi:10.1042/bj3161007a · Cited by 90
Kiriyama, T., Gillespie, M. T., Glatz, J. A., Fukumoto, S., Moseley, J. M., & Martin, T. J. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90074-t · Cited by 89
Bone destruction and hypercalcemia in plasma cell myeloma.
Mundy, G. R., & Bertolini, D. R. (1986) · PubMed · Cited by 88
Self-citationMorton, A. R., Cantrill, J. A., Pillai, G. V., McMahon, A., Anderson, D. C., & Howell, A. (1988) · BMJ · doi:10.1136/bmj.297.6651.772 · Cited by 87
Takuwa, Y., OHUE, Y., Takuwa, N., & Yamashita, K. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.6.e797 · Cited by 84
Koutsilieris, M., Frenette, G., Lazure, C., Lehoux, J., Govindan, M. V., & Polychronakos, C. (1993) · PubMed · Cited by 83
Dong, Y., & CANALIS, E. M. (1995) · Endocrinology · doi:10.1210/en.136.5.2000 · Cited by 80
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients
Pecherstorfer, M., Schilling, T., BLIND, E., Zimmer-Roth, I., Baumgartner, G., Ziegler, R., & Raue, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175989 · Cited by 78
Sato, K., Kasono, K., Fujii, Y., Kawakami, M., Tsushima, T., & SHIZUME, K. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91324-6 · Cited by 77
Hamilton, M. S., Ball, J., Bromidge, E. S., & Franklin, I. M. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04383.x · Cited by 77
Responses of Fetal Rat Bone to Thyrocalcitonin in Tissue Culture
FRIEDMAN, J., Au, W. Y. W., & Raisz, L. G. (1968) · Endocrinology · doi:10.1210/endo-82-1-149 · Cited by 77
Production of parathyroid hormone-related protein by the mammary gland of the goat
RATCLIFFE, W. A., Thompson, G. E., Caret, A. D., & Peaker, M. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1330087 · Cited by 76
Preliminary Localization of a Gene for Autosomal Dominant Hypoparathyroidism to Chromosome 3ql3
Finegold, D. N., Armitage, M. M., Galiani, M., et al. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00024 · Cited by 75
The Role of Vertebral Veins in the Dissemination of Prostatic Carcinoma
Dodds, P. R., Caride, V. J., & Lytton, B. (1981) · The Journal of Urology · doi:10.1016/s0022-5347(17)54735-7 · Cited by 75
Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cells
Barker, H. F., Hamilton, M. S., Ball, J., Drew, M., & FRANKLIN, I. M. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb08236.x · Cited by 74
Thiede, M. A., Harm, S. C., HASSON, D. M., & GARDNER, R. M. (1991) · Endocrinology · doi:10.1210/endo-128-5-2317 · Cited by 74
Hall, D. G., & Stoica, G. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090211 · Cited by 74
Parathyroid Hormone-Related Peptide in Lactation and in Umbilical Cord Blood
Khosla, S., Johansen, K. L., Ory, S. J., O’Brien, P. C., & Kao, P. C. (1990) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62164-8 · Cited by 73
Transforming growth factor β and cancer
Nørgaard, P. H., Hougaard, S., Poulsen, H. S., & Spang‐Thomsen, M. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90038-1 · Cited by 73
Skeletal metastases in advanced prostate cancer: cell biology and therapy
Koutsilieris, M. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00122-a · Cited by 73
Rogers, M. J., Watts, D. J., Russell, R. G. G., Ji, X., Xiong, X., Blackburn, G. M., Bayless, A. V., & Ebetino, F. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090710 · Cited by 73
Plawner, L. L., Philbrick, W. M., Burtis, W. J., Broadus, A. E., & Stewart, A. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14078 · Cited by 72
Funk, J. L., Krul, E. J. T., Moser, A. H., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116864 · Cited by 72
Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin
Moonga, B. S., Alam, A. S. M. T., Bevis, P. J. R., Avaldi, F., Soncini, R., Huang, C. L.-H., & Zaidi, M. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1320241 · Cited by 72
Effects of intravenous etidronate disodium on skeletal and calcium metabolism
Kanis, J. А., Urwin, G. H., Gray, R. E., Beneton, M. N. C., McCloskey, E. V., Hamdy, N. A. T., & Murray, S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90488-8 · Cited by 72
Metabolic effects of pamidronate in patients with metastatic bone disease
Vinholes, J., Guo, C., Purohit, O., Eastell, R., & Coleman, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.210 · Cited by 71
Lorente, J. A., Moróte, J., Raventos, C. X., Encabo, G., & Valenzuela, H. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66263-3 · Cited by 71
Ikeda, K., Ohno, H., HANE, M., Yokoi, H., Okada, M., Honma, T., Yamada, A., Tatsumi, Y., Tanaka, T., & Saitoh, T. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.5.1322 · Cited by 68
Sébag, M., Henderson, J. E., Goltzman, D., & Kremer, R. B. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.3.c723 · Cited by 68
Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone.
van der Pluijm, G., Vloedgraven, H. J., Ivanov, B., Robey, F. A., Grzesik, W. J., Robey, P. G., Papapoulos, S. E., & Löwik, C. W. G. M. (1996) · PubMed · Cited by 67
Samuels, M. H., Veldhuis, J. D., Cawley, C., Urban, R. J., Luther, M., Bauer, R. L., & Mundy, G. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.399 · Cited by 67
Self-citationPathophysiology and Management of Severe Hypercalcemia
Nussbaum, S. R. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30170-1 · Cited by 65
Minasian, L., Szatrowski, T. P., Rosenblum, M. K., Steffens, T. A., Morrison, M., Chapman, P. B., Williams, L., Nathan, C. F., & Houghton, A. (1994) · Blood · doi:10.1182/blood.v83.1.56.56 · Cited by 59
Southby, J., Murphy, L. M., Martin, T. J., & Gillespie, M. T. (1996) · Endocrinology · doi:10.1210/en.137.4.1349 · Cited by 59
Kohno, N., Kitazawa, S., Fukase, M., Sakoda, Y., Kanbara, Y., Furuya, Y., Ohashi, O., ISHIKAWA, Y., & Saitoh, Y. (1994) · Surgery Today · doi:10.1007/bf02032890 · Cited by 59
Walls, J., RATCLIFFE, W. A., Howell, A., & Bundred, N. J. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.270 · Cited by 58
van Zaanen, H. C. T., Koopmans, R. P., Aarden, L. A., Rensink, H. J. A. M., Stouthard, J. M., Warnaar, S. O., Lokhorst, H. M., & van Oers, M. H. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118932 · Cited by 57
Uy, H. L., Mundy, G. R., Boyce, B. F., Story, B. M., Dunstan, C. R., Yin, J. J., Roodman, G. D., & Guise, T. A. (1997) · PubMed · Cited by 55
Self-citationCANALIS, E. M., & Gabbitas, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10771 · Cited by 55
Rajan, R., Vanderslice, R., Kapur, S., Lynch, J. H., Thompson, E. W., & Djakiew, D. (1996) · The Prostate · Cited by 54
Hypercalcemia in Pregnancy and Lactation Associated with Parathyroid Hormone-Related Protein
Lepre, F., Grill, V., Ho, P. W. M., & Martin, T. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280917 · Cited by 54
Yamamoto, M., Fisher, J. E., Thiede, M. A., Caulfield, M. P., Rosenblatt, M., & Duong, L. T. (1992) · Endocrinology · doi:10.1210/endo.130.2.1733722 · Cited by 53
Uy, H., Guise, T. A., Mata, J. D. L., Taylor, S. D., Story, B. M., Dallas, M. R., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628353 · Cited by 53
Self-citationHuang, N., Kawano, M., Harada, H., Harada, Y., Sakai, A., Kuramoto, A., & Niwa, O. (1993) · Blood · doi:10.1182/blood.v82.12.3721.3721 · Cited by 51
Skeletal growth factors and aging
CANALIS, E. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1009 · Cited by 49
Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1
Guise, T. A., Garrett, I. R., Bonewald, L. F., & Mundy, G. R. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080509 · Cited by 48
Self-citationUy, H. L., Dallas, M., Calland, J. W., Boyce, B. F., Mundy, G. R., & Roodman, D. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100217 · Cited by 47
Self-citationDodwell, D. J., Abbas, S. K., Morton, A. R., & Howell, A. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90431-c · Cited by 47
Bataille, R., Chappard, D., & Klein, B. (1992) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02591662 · Cited by 46
Thiébaud, D. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390210095021 · Cited by 43
Glatz, J. A., Heath, J. K., Southby, J., O'Keeffe, L. M., Kiriyama, T., Moseley, J. M., Martin, T. J., & Gillespie, M. T. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90246-1 · Cited by 41
Transforming growth factor beta secretion from primary breast cancer fibroblasts
van Roozendaal, C. E. P., Klijn, J. G. M., Ooijen, B. V., Claassen, C., Eggermont, A. M. M., Henzen-Logmans, S. C., & Foekens, J. A. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03539-j · Cited by 39
Homotypic cell aggregations of human myeloma cells with ICAM‐1 and LFA‐1 molecules
Kawano, M. M., Huang, N., Tanaka, H., Ishikawa, H., Sakai, A., Tanabe, O., Nobuyoshi, M., & Kuramoto, A. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08085.x · Cited by 38
Lang, S., Miller, W. R., & Habib, F. K. (1995) · The Prostate · doi:10.1002/pros.2990270508 · Cited by 37
Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary
Yu, H., Diamandis, E. P., Levesque, M. A., Sismondi, P., Zola, P., & Katsaros, D. (1994) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860080412 · Cited by 37
Weissglas, M. G., Schamhart, D. H. J., Löwik, C. W. G. M., Papapoulos, S. E., Vos, P., & Kurth, K. (1995) · PubMed · Cited by 37
Huang, N., Kawano, M., Mahmoud, M., Mihara, K., Tsujimoto, T., Niwa, O., & Kuramoto, A. (1995) · Blood · doi:10.1182/blood.v85.12.3704.bloodjournal85123704 · Cited by 35
Induction of transforming growth factor beta in hormonally treated human prostate cancer
Muir, G., Butta, A., SHEARER, R. J., Fisher, C., Dearnaley, D. P., Flanders, K. C., Sporn, M. B., & Colletta, A. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.21 · Cited by 35
Bisphosphonates in the Treatment of Bone Diseases
Delmas, P. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352409 · Cited by 33
Gold, J. E., Malamud, S. C., Larosa, F., & Osband, M. E. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830440109 · Cited by 32
Treatment of skeletal disease in breast cancer with clodronate
Paterson, A. H. G., Ernst, D. S., Powles, T. J., Ashley, S., McCloskey, E. V., & Kanis, J. А. (1991) · Bone · doi:10.1016/8756-3282(91)90063-o · Cited by 31
Weissglas, M. G., Schamhart, D. H. J., Löwik, C. W. G. M., Papapoulos, S. E., Vos, P., & Kurth, K. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67735-8 · Cited by 30
Kostenuik, P. J., Singh, G., Suyama, K. L., & Orr, F. W. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00133469 · Cited by 29
Prostate-derived soluble factors block osteoblast differentiation in culture
Martínez, J., Silva, S., & Santibanez, J. F. (1996) · Journal of Cellular Biochemistry · Cited by 28
Quantitative bone histomorphometry in nude mice bearing a human squamous cell lung cancer
Kukreja, S. C., Rosol, T. J., Shevrin, D. H., et al. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030314 · Cited by 24
Mechanisms of preferential metastasis of breast cancer to bone - (Review)
Yoneda, T. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.1.103 · Cited by 23
Wysolmerski, J. J., Vasavada, R. C., Foley, J., Weir, E. C., Burtis, W. J., Kukreja, S. C., Guise, T. A., Broadus, A. E., & Philbrick, W. M. (1996) · PubMed · Cited by 23
Self-citationBasic fibroblast growth factor inhibits osteoclast-like cell formation
Jimi, E., Shuto, T., Ikebe, T., Jingushi, S., Hirata, M., & Koga, T. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199608)168:2<395::aid-jcp18>3.0.co;2-2 · Cited by 22
Pizurki, L., Rizzoli, R., Caverzasio, J., & Bonjour, J. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650061114 · Cited by 20
Cleton, F. J., van Holten-Verzantvoort, A. T., & Bijvoet, O. L. M. (1989) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-83668-8_7 · Cited by 20
Bone Invasion by Walker 256 Carcinoma, Line A in Young and Adult Rats: Effects of Etidronate
Bassani, D., Sabatini, M., Scanziani, E., Francesco, L. D., Coccioli, G., GUAITANI, A., & Bartošek, I. (2009) · Oncology · doi:10.1159/000226810 · Cited by 15
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Extracellular Calcium Sensing and Extracellular Calcium Signaling
Brown, E. M., & MacLeod, R. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.239 · Cited by 1,388
OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism
Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J., & Choi, Y. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090646 · Cited by 724
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Self-citation
Metadata
- Authors
- Guise, T. A., & Mundy, G. R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1998-02-01
- Volume
- 19
- Issue
- 1
- Pages
- 18-54
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2616256733
- Cited by
- 472
- References
- 288
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.